VEGFA and neoplasm: Tumor-derived angiopoietin-2 (Ang-2) induces chemotactic activity in TEMs [152,153], which have been associated with resistance to therapies that block VEGF and VEGFR-2 and with the development of an invasive phenotype [154,155].